Cutler Group’s Alder Biopharmaceuticals ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,500
| Closed | -$28K | – | 4974 |
|
|
2019
Q3 | $28K | Buy |
+1,500
| New | +$17.2K | ﹤0.01% | 1954 |
|
|
2018
Q2 | – | Sell |
-1,160
| Closed | -$14K | – | 5246 |
|
|
2018
Q1 | $14K | Sell |
1,160
-8,541
| -88% | -$124K | ﹤0.01% | 2564 |
|
|
2017
Q4 | $111K | Sell |
9,701
-6,324
| -39% | -$70.6K | ﹤0.01% | 1313 |
|
|
2017
Q3 | $196K | Sell |
16,025
-26,945
| -63% | -$281K | 0.01% | 1193 |
|
|
2017
Q2 | $492K | Buy |
42,970
+36,089
| +524% | +$667K | 0.02% | 702 |
|
|
2017
Q1 | $143K | Sell |
6,881
-6,002
| -47% | -$133K | 0.01% | 1442 |
|
|
2016
Q4 | $267K | Buy |
12,883
+7,811
| +154% | +$203K | 0.01% | 1097 |
|
|
2016
Q3 | $166K | Sell |
5,072
-3,019
| -37% | -$91.9K | 0.01% | 1384 |
|
|
2016
Q2 | $202K | Buy |
8,091
+1,743
| +27% | +$47.2K | 0.01% | 1118 |
|
|
2016
Q1 | $155K | Buy |
6,348
+915
| +17% | +$21.2K | 0.01% | 1205 |
|
|
2015
Q4 | $179K | Buy |
+5,433
| New | +$184K | 0.01% | 1276 |
|